Familial Pulmonary Fibrosis Study
The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis. Finding the genes that are associated with pulmonary fibrosis is the first step to develop better methods for early diagnosis and improved treatments. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis.
Who should apply?
To be eligible for this study you must have at least 2 members of your family diagnosed with Idiopathic Interstitial Pneumonia (IIP). You may be included in this number.
For affected individuals, we confirm your diagnosis by reviewing your medical records (such as chest CT scans, pulmonary function tests and biopsy results if applicable). We also ask for a medical history questionnaire to be filled out and obtain a sample of blood or tissue for genetic studies.
Unaffected first-degree family members (parents, siblings, and children) may also be screened with a questionnaire, and a blood sample is obtained for genetic studies. Some members may be requested to undergo a high-resolution CT (HRCT) scan if they meet certain criteria.
Records are requested on deceased family members who carried the diagnosis of pulmonary fibrosis.
National Jewish Health – Families previously enrolled at NJH, NJH clinical patients and general FPF genetic questions
1400 Jackson Street, F107
Denver, CO 80206
Contact: Janet Talbert, MS, CGC - Certified Genetic Counselor
1.800.423-8891 ext. 1022
University of Colorado Denver – National Recruitment
12631 E 17th Ave
Aurora, CO 80045
Contact: Julie Powers, MHS
Clinical Research Coordinator
Vanderbilt University Medical Center – Local and National Recruitment
T-1218 Medical Center North
Vanderbilt University Medical Center
Nashville, TN 37232-2650
Contact: Cheryl Markin, MT - IPF Study Coordinator
Landspitali University Hospital, Reykjavik, Iceland- Icelandic recruitment only
David Schwartz, MD, Principal Investigator, National Jewish Health
Kevin K. Brown, MD, National Jewish Health
Gregory P. Cosgrove, MD, National Jewish Health
Tim Bedient, MD, National Jewish Health
Roland M. du Bois, MD, National Jewish Health and National Heart & Lung Institute, Imperial College
Marvin Schwarz, MD, University of Colorado Denver
Mark P. Steele, MD, Duke University
James E. Loyd, MD, Vanderbilt University School of Medicine
Gunner Gudmundsson, MD, Landspitali University Hospital, Reykjavik, Iceland
Dolly Kervitsky, RCP, CCRC, National Jewish Health
Janet Talbert, MS, CGC, National Jewish Health
Raven Kidd, CCRC, Duke University
Cheryl Markin, MT, Vanderbilt University
Tasha Fingerlin, PhD, University of Colorado Denver
Nathan Kummer, National Jewish Health
Max Seibold, PhD, National Jewish Health
Leah Luna, PhD, National Jewish Health
Jennifer Cotter, MS, National Jewish Health
Elissa Murphy, MS, National Jewish Health